Paper 27 - CHONDROSARCOMAS ARE UNIQUELY INFILTRATED WITH MUCOSAL ASSOCIATED INVARIANT T CELLS AND CAN BE TARGETED WITH POTENT REGULATABLE MEMBRANE BOUND IL15 TIL

Author(s)

• 

  Rusul EM Al-Marayaty, MD (she/her/hers)

  Dr
  Northwestern University
  Washington, District of Columbia, United States

  Slides

Co-Author(s)

• ZA

  Zheng Ao, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• BA

  Bulent Arman Aksoy, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• FO

  Farres Obeidin, MD

  UCLA
  Los Angeles, California, United States
• RB

  Rachel Burga, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• SA

  Samer Attar, MD

  Surgeon
  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• TP

  Terrance Peabody, MD

  Chair, Department of Orthopaedics
  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• 

  Pedro Hermida De Viveiros, MD

  Assistant Professor
  Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  Chicago, Illinois, United States
• JN

  Juliana Ng, Bachelors in Biochemistry, Masters in Data Analysis

  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• WJ

  Weiqing Jing, PhD

  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• HS

  Himaly Shinglot, Bachelors in Pharmacy, Masters in Biotechnology

  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• AZ

  Ali Zhang, MD

  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• NA

  Nourhane Al Akoum, MD

  Northwestern University, Feinberg School of Medicine
  Chicago, Illinois, United States
• AV

  Alonso Villasmil Ocando, Bachelor of Arts degree in Biology and Public Health

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• NR

  Nishita Roy, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• AA

  Andres Alvarado, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• DS

  Dexue Sun, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• DS

  Dhruv Sethi, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• MO

  Michelle Ols, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• JT

  Jan Ter Meulen, PhD

  Obsidian Therapeutics
  Cambridge, Massachusetts, United States
• 

  Seth M. Pollack, MD

  Sarcoma Program Director
  Northwestern University Feinberg School of Medicine
  Chicago, Illinois, United States